BACKGROUND: Chronic discoid lupus erythematosus (CDLE) is present in 15-30% of patients with systemic lupus erythematosus (SLE). Approximately 5% of CDLE cases can evolve to SLE at some stage of the disease. AIM: The aim of this study was to determine gene frequencies of HLA-DRB1 alleles in Mexican mestizo patients with CDLE, irrespective of the presence of systemic disease. METHODS: The study comprised 28 Mexican mestizo patients with CDLE who were attending the Passover Dermatology Centre, in Mexico City. HLA-DRB1 and DQ allele typing was performed by sequence-specific oligotyping after DNA amplification using PCR. The study also included 99 ethnically matched healthy individuals as controls. RESULTS: In the patient group, a significantly increased gene frequency was found for the HLA-DR4 (P = 0.016, OR = 2.24, 95% CI 1.14-4.38) and HLA-DR16 alleles (P = 0.005, OR = 5.51, 95% CI 1.49-21.08). CONCLUSION: HLA-DRB1 alleles seem to be involved in the genetic susceptibility to CDLE in the Mexican mestizo population.
BACKGROUND:Chronic discoid lupus erythematosus (CDLE) is present in 15-30% of patients with systemic lupus erythematosus (SLE). Approximately 5% of CDLE cases can evolve to SLE at some stage of the disease. AIM: The aim of this study was to determine gene frequencies of HLA-DRB1 alleles in Mexican mestizo patients with CDLE, irrespective of the presence of systemic disease. METHODS: The study comprised 28 Mexican mestizo patients with CDLE who were attending the Passover Dermatology Centre, in Mexico City. HLA-DRB1 and DQ allele typing was performed by sequence-specific oligotyping after DNA amplification using PCR. The study also included 99 ethnically matched healthy individuals as controls. RESULTS: In the patient group, a significantly increased gene frequency was found for the HLA-DR4 (P = 0.016, OR = 2.24, 95% CI 1.14-4.38) and HLA-DR16 alleles (P = 0.005, OR = 5.51, 95% CI 1.49-21.08). CONCLUSION:HLA-DRB1 alleles seem to be involved in the genetic susceptibility to CDLE in the Mexican mestizo population.
Authors: Yesenia Santiago-Casas; Luis M Vilá; Gerald McGwin; Ryan S Cantor; Michelle Petri; Rosalind Ramsey-Goldman; John D Reveille; Robert P Kimberly; Graciela S Alarcón; Elizabeth E Brown Journal: Arthritis Care Res (Hoboken) Date: 2012-05 Impact factor: 4.794
Authors: Walid Wadi; Noor Eldeen A M Elhefny; Essam H Mahgoub; Adel Almogren; Khaled D Hamam; Hamad A Al-Hamed; Gasim I Gasim Journal: Int J Health Sci (Qassim) Date: 2014-04
Authors: Rafael Garcia-Silva; Susana Hernandez-Doño; Jeniffer Patricia Román-Amparo; Ma Guadalupe Trujillo-Vizuet; Blanca Aurora Mena-Vela; Andrea Rizo-Pinto; José Manuel Pérez Tirado; José Hiram Cetina-Díaz; Pedro Bulos-Rodríguez; Julio Granados; Jesús Sepúlveda-Delgado Journal: Clin Rheumatol Date: 2021-02-11 Impact factor: 2.980
Authors: Saleh Al-Motwee; Dunia Jawdat; Ghassan S Jehani; Hanan Anazi; Abdullah Shubaili; Paul Sutton; Aytul F Uyar; Ali H Hajeer Journal: Ann Saudi Med Date: 2013 May-Jun Impact factor: 1.526